ExpressionEdits
About ExpressionEdits
ExpressionEdits utilizes its Genetic Syntax Engine, an AI-driven computational platform, to optimize transgene design through intronization. This technology precisely edits genetic grammar to unlock the expression of previously inaccessible proteins for therapeutic applications. The platform enhances gene expression and potency, enabling the development of high-value protein therapeutics and optimizing existing gene therapy constructs.
```xml <problem> Low protein yield and functionality pose significant challenges in biotechnological applications, hindering advancements in drug discovery, synthetic biology, and biomanufacturing. Traditional methods of optimizing protein expression often fall short, resulting in inefficient processes and limited production of desired proteins. </problem> <solution> ExpressionEdits leverages AI-driven intronization technology to redesign synthetic DNA instructions, significantly enhancing protein expression efficiency. By optimizing the design of synthetic genes, ExpressionEdits ensures higher protein yields and improved functionality. The technology addresses the limitations of conventional protein expression methods, leading to more efficient and productive biotechnological processes. This innovative approach enables researchers and manufacturers to overcome bottlenecks in protein production, accelerating advancements in various fields. </solution> <features> - AI-driven intronization technology for optimized synthetic DNA design - Enhanced protein expression efficiency, leading to higher yields - Improved protein functionality for diverse biotechnological applications </features> <target_audience> ExpressionEdits serves researchers and manufacturers in drug discovery, synthetic biology, and biomanufacturing who require efficient and high-yield protein expression. </target_audience> ```
What does ExpressionEdits do?
ExpressionEdits utilizes its Genetic Syntax Engine, an AI-driven computational platform, to optimize transgene design through intronization. This technology precisely edits genetic grammar to unlock the expression of previously inaccessible proteins for therapeutic applications. The platform enhances gene expression and potency, enabling the development of high-value protein therapeutics and optimizing existing gene therapy constructs.
Where is ExpressionEdits located?
ExpressionEdits is based in Haverhill, United States.
When was ExpressionEdits founded?
ExpressionEdits was founded in 2021.
How much funding has ExpressionEdits raised?
ExpressionEdits has raised $9.5M.
Who founded ExpressionEdits?
ExpressionEdits was founded by Devika Thapar.
- Devika Thapar - Co-founder
- Location
- Haverhill, United States
- Founded
- 2021
- Funding
- $9.5M
- Employees
- 22 employees
- Investors
- Octopus VenturesredalpineAmino CollectiveBlueYard Capital